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Background: Well-designed randomised clinical trials (RCTs) provide the best evidence to inform decision-making
and should be the default option for evaluating surgical procedures. Such trials can be challenging, and surgeons’
preferences may influence whether trials are initiated and successfully conducted and their results accepted.
Preferences are particularly problematic when surgeons’ views play a key role in procedure selection and patient
eligibility. The bases of such preferences have rarely been explored. Our aim in this qualitative study was to investigate
surgeons’ preferences regarding the feasibility of surgical RCTs and their understanding of study design issues using
breast reconstruction surgery as a case study.
Methods: Semistructured qualitative interviews were undertaken with a purposive sample of 35 professionals
practicing at 15 centres across the United Kingdom. Interviews were transcribed verbatim and analysed thematically
using constant comparative techniques. Sampling, data collection and analysis were conducted concurrently and
iteratively until data saturation was achieved.
Results: Surgeons often struggle with the concept of equipoise. We found that if surgeons did not feel ‘in equipoise’,
they did not accept randomisation as a method of treatment allocation. The underlying reasons for limited equipoise
were limited appreciation of the methodological weaknesses of data derived from nonrandomised studies and little
understanding of pragmatic trial design. Their belief in the value of RCTs for generating high-quality data to change or
inform practice was not widely held.
Conclusion: There is a need to help surgeons understand evidence, equipoise and bias. Current National Institute of
Health Research/Medical Research Council investment into education and infrastructure for RCTs, combined with
strong leadership, may begin to address these issues or more specific interventions may be required.
Keywords: Breast reconstruction, Education, Methodology, Qualitative, Randomised clinical trialsBackground
Patients and surgeons need high-quality information
about treatment outcomes to inform decision-making
[1]. It is increasingly recognised that well-designed ran-
domised clinical trials (RCTs) provide the best evidence
for the effectiveness of an intervention, and, although
not suitable for addressing all research questions, they* Correspondence: Shelley.Potter@bristol.ac.uk
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unless otherwise stated.should be the default option for evaluating many, if not
all, surgical procedures [2-4]. Surgical trials are difficult
to conduct [5], however, and challenges in the implemen-
tation of well-designed, pragmatic, multicentre RCTs for
surgical procedures have been well-documented [6-8].
Particular challenges relate to the preferences and beliefs
of participating surgeons [5,9]. These factors may influ-
ence whether a trial is initiated [5], whether participants
are recruited effectively [10] and whether the results are
accepted and subsequently used to influence practice [3].
A particular challenge is encountered in the effective
design and conduct of surgical RCTs in which there are
several treatment options and in which patient andtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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tion and patient eligibility. Breast reconstruction (BR)
after mastectomy for breast cancer is one such example,
where possible interventions include simple implant-
based reconstruction, pedicled flap reconstruction in-
cluding the latissimus dorsi flap, or free flap procedures
such as the deep inferior epigastric perforator (DIEP)
flap using skin and fat from the lower abdominal wall
[11,12]. Since 1995, just 13 BR RCTs [13-24] have been
conducted and only 2 have addressed major questions
such as the optimal type [24] or timing [25] of surgery.
Both of these latter two trials were small, single-centre
studies which failed to meet recruitment targets. System-
atic reviews have summarised the randomised and
nonrandomised evidence for BR surgery [26,27] and
highlighted the lack of high-quality research in this area.
Although many of the investigators of the nonrando-
mised studies commented on the limitations of their
observational data and the hypothetical need for rando-
mised trials [28-31], prevailing expert opinion suggests
that RCTs in BR would be ‘unethical’, ‘impractical’ and/or
‘inappropriate’ [11,28-36] because of the importance of
patient and surgeon preference in procedure selection.
These claims and, more broadly, how surgeons’ prefer-
ences may influence participation in surgical trials in
general have rarely been explored in depth. Qualitative
interviews are an excellent method for exploring difficult
or sensitive issues [37], such as the basis of surgeons’
preferences, and are increasingly used in the develop-
ment of trial methodology [9,38]. Our aim in the Breast
Reconstruction and Valid Evidence (BRAVE) study was
therefore to use qualitative methods to explore surgeons’
preferences and beliefs to gain an understanding of how
these factors may influence the feasibility of surgical
RCTs using hypothetical trials in BR as a case study.
Methods
This study received full ethical approval from the
Southmead Research Ethics Committee (reference number
09/H0102/50).
Health-care professional recruitment
Opinion leaders in BR surgery were hypothesised to be
key informants regarding the feasibility of randomisation
in BR because they would be most likely to participate
in any future trial. Our sampling strategy therefore ini-
tially targeted surgeons practicing at high-volume cen-
tres offering advanced training fellowships.
Sampling and recruitment
Access to this group of opinion leaders was gained by a
committee composed of experienced breast and plastic
surgeons and representatives of British professional asso-
ciations. A 10-minute presentation was made to thegroup outlining the study, and committee members were
invited to participate. Surgeons from high-volume centres
that were not represented at the meeting were sent perso-
nalised e-mail invitations. Other surgeons with potentially
interesting views on randomisation who were recom-
mended by key informants were similarly approached.
Colleagues, clinical nurse specialists (CNSs) and psy-
chologists at centres of consenting surgeons were also
invited to participate. Nonrespondents were sent an
electronic reminder after 3 weeks. Surgeons who did
not respond thereafter were considered to have declined
study participation.
Maximum variation sampling [39] was initially employed
such that male and female surgeons with a range of ex-
perience from different geographical and sociodemo-
graphic centres across the United Kingdom were initially
included [40,41]. As the study progressed, theoretical sam-
pling was introduced to purposively select individuals
whose views might add new perspectives to those already
represented in an attempt to disprove or contradict emer-
ging theories and allow those theories to be further refined
[41,42]. This included seeking deviant or negative cases,
such as surgeons who had previously expressed positive
views about RCTs in the BR literature or at national meet-
ings. Sampling, data collection and data analysis were con-
ducted concurrently and iteratively [43] and continued
until data saturation was achieved and no new themes
emerged from the analysis [44].
Data collection
All interviews were conducted by a female, medically
qualified researcher (SP). A semi-structured topic guide for
the interviews was developed on the basis of literature re-
views and the researcher’s clinical experience (Additional
file 1: Study Topic Guides Healthcare Professional Semi-
structured Interview Schedule for the BRAVE study
investigating the feasibility of clinical trials in BR; see
Additional file 1).
The topic guide included a series of open questions
covering issues related to RCTs in BR to allow partici-
pants to direct the discussion, and the questions were it-
eratively modified as the study progressed to enable
exploration of emerging themes in later interviews. All
interviews were digitally audio-recorded, transcribed ver-
batim and anonymised using study pseudonyms. Tran-
scripts were compared with the audio recordings to
ensure accuracy. Reflective notes were made after each
interview and taken into account in the analysis.
Data analysis
Data were analysed using a grounded theory approach
as described by Glaser and Strauss [45]. The aim of
grounded theory is to generate new theories about phe-
nomena that develop from, or are ‘grounded’ in, the data
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terised by an inductive–deductive interplay in which
sampling, data collection, analysis and theorising occur
iteratively or cyclically throughout the study [47]. The
central principle of grounded theory is that of constant
comparison [48] in which new findings are compared
with existing data to identify similarities and differences
and emerging theories refined with the ongoing assimila-
tion of the data [46].
Our data analysis was therefore initiated soon after
data collection commenced and was an ongoing and it-
erative process that informed further sampling. The pur-
pose of the analysis was to summarise participants’
views and develop theoretical explanations for their
opinions. Interviews were analysed inductively in small
batches by systematically assigning codes that captured
the meaning of the words to segments of text. Emerging
codes were then grouped into similar themes and
explored in subsequent interviews. In further analysis,
we employed the constant comparison technique of
grounded theory [45], in which new findings were com-
pared with existing data to identify similarities and dif-
ferences within themes, taking into account the context
in which these themes were discussed. Emerging theor-
ies were developed and refined through ongoing assimi-
lation of the data. This method ensured that findings
were systematically compared and grounded in the data.
Early codes were subsequently modified and refined, or
new codes were added, as the interviews and analyses
progressed. The views of individual professionals were
compared and contrasted with those of other partici-






Years as consultant/CNSa experience
<5 years 4
6 to 15 years 3
>15 years 4
Median (range) 14 (0 to 23)b
Number of BRs performed per year
<20 4c
20 to 50 3
>50 4
Median (range) 30 (0 to 200)
aCNS, Clinical nurse specialist; NA, Not applicable. bThis group included one senior t
who did not perform breast reconstruction surgery.attitudes toward RCTs, including profession, surgical
speciality, geographical location, experience, gender and
previously expressed opinions. Individuals exhibiting
contrasting attitudes (‘negative cases’) were studied in
detail to gain a deeper understanding of the data. The
analysis was conducted by a single researcher (SP) with
checking of coding [49] and the plausibility of the data
interpretation carried out by an experienced social scien-
tist (NM) and a surgeon (JMB) and by triangulation of
health-care professionals’ views [49] to ensure the valid-
ity of the data [40,42,44,49-52].
Results
Participant demographics
Of 48 invitees, 34 (71%) responded, but 3 interviews
could not be arranged. A total of 31 interviews (67% of
invitees) at a total of 15 centres were conducted with 11
oncoplastic breast surgeons (OPBSs), 11 plastic sur-
geons, 11 CNSs (including two interviews with pairs of
CNSs) and 2 clinical psychologists. The surgeons per-
formed a median of 30 primary BR operations annually
(range, 0 to 290). The majority of surgeons were male
(n = 17) with a median of 13 years’ experience as consul-
tants (range, 0 to 29 years) (Table 1).
No differences were identified in the demographics of
surgeons who participated in the study compared with
those who did not. Participants’ perceptions of decision-
making and access to care are reported elsewhere [53].
Participants’ acceptance of randomisation
None of the professionals perceived randomisation to
different types of BR surgery (implant, pedicled or freecipants
Plastic surgeons Clinical nurse specialists Clinical psychologists










40 (10 to 290)
rainee not yet appointed as a consultant. cThis group included two surgeons
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although the reasons for their strong views were often
not clearly articulated and seemed to be overwhelmingly
related to their own strong preferences.
“Implants, flap from the back, flap from the tummy,
which are the three ways of making a breast as far as
I’m concerned—to randomise between those is
something that’s largely inappropriate.” (Mr O, plastic
surgeon, centre 8)
“When you get appendicitis, you have to have an
operation, the doctor tells you, ‘Listen, you need an
operation’…. This is completely different. I think the
patient has to be involved with the choice.... [T]hey
have to be happy with the choice … and feel very
comfortable with the decision that’s been made. I
think that you’re on a hiding to nothing [have no
chance of succeeding] [with randomisation].” (Mr T,
plastic surgeon, centre 12
When surgeons reported that the different interven-
tions might have equivalent outcomes, they did agree
that randomisation was acceptable; however, they felt
that comparisons within specified procedure types (for
example, between different types of implants or different
forms of lower-pole coverage in implant reconstruction)
were more acceptable than comparisons between the
very different surgical types of BR (n = 23).
“If there were patients in whom there was equipoise
an’ in which … one type of reconstruction versus
another type would be equally suitable … to
randomise those patients, I wouldn’t have a
problem … with that.” (Mr G, plastic surgeon,
centre 4)
“If we think an abdominal flap is appropriate, you can
be randomised between a pedicled TRAM [transverse
rectus abdominis myocutaneous] and a DIEP, yeah, I’d
be happy with that.... I would be happy with
randomising also in other areas where I have
equipoise so if I’m able to say this patient is suitable
for … an implant and an autologous LD [latissimus
dorsi] … or between a TRAM and an implant and a
LD [latissimus dorsi pedicled flap], or a TRAM and a
DIEP, so that would be combinations of randomisation
that I would be happy with, but just a broad
randomisation I wouldn’t be happy with.” (Mr C,
OPBS, centre 1)
“I am involved in other trials that look at subgroups,
and I think that is fair enough because it doesn’t
interfere with the basic choice. If you want animplant, then you get an implant, but whether you get
implant A or implant B is then probably not as
crucial, … and provided the patient had enough
information and can give informed consent, then I
think that’s a fair enough thing to do.” (Miss W,
plastic surgeon, centre 15)
Understanding participants’ attitudes toward
randomisation
Professionals’ acceptance of randomisation was observed
to be largely influenced by two factors: (1) their under-
standing of the limitations of existing data and hence the
need for RCTs to generate high-quality evidence in BR
and (2) their understanding and acceptance of pragmatic
trial design.
Limited understanding of problems with existing evidence
and need for RCTs in breast reconstruction
A number of professionals did not appear to understand
why randomised trials in BR are necessary. This lack of
understanding seemed to be due to a limited appreci-
ation of the importance of randomisation in minimising
bias. Several professionals said they would refuse ran-
domisation as a method of treatment allocation to deter-
mine treatment effectiveness because they perceived that
equivalent data could be produced by utilising a number
of nonrandomised study designs that included clinical
audits.
“I’m telling you how the information that you’re
trying to capture from the randomised trial can be
captured just by having a good audit.” (Mr J, OPBS,
centre 6)
“It is very important that we do produce good long-
term outcome data.... [D]o you actually need a
randomised controlled trial to produce that data?”
(Mr G, plastic surgeon, centre 4)
“We’re always talking about randomised controlled
trials…. I would’ve thought, to be honest with you, a
far better way is about PROMS [patient-reported
outcome measures]…. [I]t’s about the patient-reported
outcome measures…. I mean, I think it’s far, far more
valuable than a randomised controlled trial.” (Mr T,
plastic surgeon, centre 12)
“I just wonder if we need to think a little more
laterally about how we assess breast reconstruction….
I know that randomisation is seen as the gold
standard, but that’s the gold standard for drugs, not
necessarily for surgery, and I just wonder whether
there are other ways and other mechanisms that we
should be exploring.” (Miss N, OPBS, centre 7)
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ant were happy to consider randomisation in situations
where they believed equipoise to exist:
“There are loads of questions that are not answered.
Different manufacturers … one-stage implants as
against two-stage, so Becker-35 or a McGhan-150
[different types of implants] against the tissue
expander followed by a permanent implant. I would
be quite comfortable doing those types of trials be-
cause I think they’re equivalent and I really, genuinely
don’t know the answer.” (Mr H, OPBS, centre 5)
Randomisation was rejected when equipoise was per-
ceived to be absent. For the majority of professionals,
however, perceptions of equipoise were largely based on
observational data, personal experience or surgical dogma.
“I’ve got a fairly clear idea of who I think will benefit
from [a type of BR].... I would find it difficult to
randomise the patients, because my experience has
already shown me that they get a better cosmetic
outcome.” (Miss N, OPBS, centre 7)
A minority of surgeons recognised this point and hence
the need for RCTs to address important questions.
“[I]t’s almost (laughing) a religious fervour that DIEPs
are good and pedicled TRAMs are bad, and yet I’m
not aware of any good, even-handed evidence to
support that.” (Mr H, OPBS, centre 5)
The majority of participants, however, did not appear
to appreciate the methodological limitations of the stud-
ies on which their perceptions were based or the impact
of selection bias on the results. Some surgeons commen-
ted that the absence of robust evidence did not equate
to the existence of equipoise.
“Theoretically, anywhere where we haven’t got a
robust evidence base from randomised trials, you have
to say there’s equipoise, but we know that that’s just
not the case.” (Mr I, OPBS, centre 6)
A number of surgeons reported that they felt that
things had ‘moved on’ in BR and that trials are no longer
necessary.
“I’m all for well-designed studies that prove stuff that
answers the tricky questions, but, I dunno, I think it’s
almost that things have moved on a bit in breast
reconstruction…. We’ve now got this toolbox of
techniques, and I think it’s now refining those actually
and trying to make sure that patients access the righttechnique for them, I think that’s more the way things
should be moving, rather than having two theories that
are equal or that seem about the same…. I think we
kind of know that.” (Mr O, plastic surgeon, centre 8)
Limited understanding and acceptance of pragmatic
trial design
Although a number of professionals reported that they
felt RCTs are needed, many expressed concerns which
reflected limited understanding of pragmatic trial design.
“Each patient is unique—they really are, and it’s [not]
like a drug trial where we don’t know the answers. I
think there’s so many variables for these patients.”
(Mr L, plastic surgeon, centre 6)“Randomisation … in a nonblinded trial is not as robust
as people would like to think it is ’cause it’s heavily
affected by patient factors and physician factors, so
there’s no doubt, epidemiology is not randomised and it
gives you robust outcomes. You wouldn’t need to run a
randomised controlled trial of smoking or excessive
alcohol intake to convince people that it causes
damage. You wouldn’t need to randomise people to two
bottles of vodka a day—or not so—to have a robust
view about alcohol.” (Mr I, OPBS, centre 6)
A number of surgeons expressed concerns about the
complexity of the procedure and the impact it might
have on the trial results.
“There are so many variables involved with creating a
randomised trial…. Scientifically, you’ll be hounded by
people saying that there are so many variables in this
that it’s not valid.” (Mr L, plastic surgeon, centre 6)
“The problem with trials is that you have to control for
everything…. [I]t’s very easy to set up a trial and find that
you’ve actually introduced some bias by something that
you’ve done wrong.” (Mr O, plastic surgeon, centre 8)
Many participants were concerned about variations in
both the surgeons’ levels of expertise and the procedures
themselves and felt that these might invalidate or sub-
vert study findings.
“There’s such a variability that I’m just concerned that
say you compare implants and lat [issimus] dorsi’s
that you’d be mixing some surgeons who are really
not good at lat dorsi’s…., an’ then you’re going to end
up saying ‘well the implant gives a nicer result’…. It’s
going to skew things unless you have a sort of
baseline standardisation of training.” (Miss E, plastic
surgeon, centre 3)
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the same techniques. Some people change the
submammary fold, they lift the thoracoepigastric skin
and recreate the sub-mammary fold. Now that’s gonna
be totally different from someone who’s keeping the old
sub-mammary fold in an immediate reconstruction.”
(Mr U, plastic surgeon, centre 14)
Others were concerned about selection bias in a trial:
“By selecting out cases that could go into [the trial],
you’re introducing bias … because you’re using your
judgement as a clinician to decide who could have
one or the other rather than it being a truly
randomised process.” (Mr D, OPBS, centre 2)
It’s double-blind randomised controlled trials that are
the gold standard, and I don’t see nonblinded, if you
like, open-label trials as a gold standard ’cause they’re
subject to all sorts of problems, particularly about
selection.” (Mr I, OPBS, centre 6)
These concerns appeared to adversely influence pro-
fessionals’ desire to participate in RCTs that they felt
would not generate valid or generalisable results and
thus would not impact clinical practice.
Discussion
Surgical interventions should be evaluated in the context
of well-designed, pragmatic, multicentre RCTs because
high-quality evidence can guide health policy and clin-
ical decision-making and provide a standard of care for
patients considering surgery. Surgical trials are challen-
ging, however, and surgeons’ preferences are an estab-
lished barrier to their participation and recruitment of
patients into trials [7,54]. Our present exploratory, quali-
tative study including 35 professionals produces further
evidence that surgeons do not always accept RCTs or
the results. It also provides new data suggesting that sur-
geons’ rejection of this methodology may be related to
their limited understanding of the importance of ran-
domisation in allowing the outcomes of surgical proce-
dures to be fully evaluated, as well as pragmatic trial
design issues. Interventions designed to improve profes-
sionals’ understanding of the need for trials and prag-
matic trial methodology are therefore recommended.
Surgeons’ preferences are a well-recognised and ac-
cepted barrier to their participation in trials [10,55-58]
but investigators in previous studies have not tried to
understand these preferences, how they are formed or
the evidence on which they are based, although there is
some data to suggest that surgeons’ understanding is
limited [56]. By contrast, several studies have explored
the basis of patients’ treatment preferences [59-62].Training research nurse trial recruiters to explore pa-
tients’ preferences has been shown to facilitate recruit-
ment of participants into a RCT of watchful waiting,
radical radiotherapy and surgery in patients with early
prostate cancer [61]. It is possible that such an interven-
tion might be effective in aiding surgeons to recruit pa-
tients into RCTs. The limited understanding of pragmatic
trial methodology identified in this study is consistent with
the findings of a similar previous study conducted with
surgeons who had participated in the Spinal Stabilisation
Trial (SST) [9], a multicentre, pragmatic RCT comparing
an intensive functional rehabilitation programme with sur-
gery for the treatment of chronic lower-back pain. In ac-
cordance with the views of the participants in the present
study, surgeons recruiting patients into the SST were un-
sure about the study’s aims or the nature of the compari-
sons and expressed concerns about the flexible eligibility
criteria, which they felt would invalidate the study’s final
results. These views had a negative impact on both re-
cruitment during the study and acceptance and interpret-
ation of the study findings. Therefore, a growing body of
evidence suggests that surgeons may have a limited under-
standing of trial methodology.
Although our present study is novel, it may not reflect
the true acceptability of RCTs to surgeons, because par-
ticipants were asked to consider hypothetical trial par-
ticipation. The similarities between the findings of this
study and the SST, however, suggest that the presence of
this potential weakness is unlikely. It is also possible that
the researcher shaped the study in that, by knowing they
were speaking with a physician, the surgeons responded
in a particular way. Several strategies were used to en-
sure the validity of the study data [42,49] and reduce the
risk of bias [40,42,44,49-52]. These approaches included
triangulation of the health professionals’ views [49], mul-
tiple coding of transcripts [49] and checking of data in-
terpretation by the research team. Throughout the
study, care was taken to ensure the inclusion of negative
cases and the use of ‘fair dealing’, such that multiple dif-
fering perspectives have been reported and the viewpoint
of only one group has not been presented as the sole
truth [42]. Particular attention was paid to the issue of
reflexivity and the way in which the researcher, a female
medically qualified general surgical trainee (SP) with
clinical and research experience with BR, may have
shaped the data collection and analysis, as well as how
this factor might potentially have influenced the presen-
tation of the results [63]. A clear and comprehensive de-
scription of the methods of data collection and analysis
have been provided with a range of quotations to illus-
trate the themes and theories discussed, thus allowing
readers to judge for themselves whether the conclusions
drawn are adequately supported by the data [42]. Al-
though this study involved surgeons who perform BR
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and may provide novel insights into the ways in which
recruitment into surgical trials may be improved.
Well-designed RCTs in surgery are vital to generate
high-quality data to guide decision-making, and it is es-
sential that future RCTs be conducted to rigorously
evaluate new surgical innovations [2,4] before the proce-
dures are introduced into routine practice. This consid-
eration is of particular importance in operations such as
BR, where available procedures differ markedly in cost
and evidentiary proof of effectiveness or superiority are
necessary to justify diversion of scarce resources to the
use of novel techniques while protecting patients from
potential harm [64].
RCTs are traditionally unfamiliar to surgeons, however
[65]. Unlike drugs, which require robust evaluation before
they are approved for use, there are no stringent require-
ments for the introduction of new procedures in surgery
[66-71]. Infrastructure to facilitate high-quality surgical re-
search has also been lacking. There has therefore been lit-
tle impetus for surgeons to engage in time-consuming and
often challenging research [4,5,7,8,72-75], and many early
trials failed because of poor recruitment [21]. Embedding
qualitative research into surgical trial design is one way in
which these problems may be successfully explored and
overcome [38,76]. By highlighting previously unantici-
pated issues relating to a lack of understanding of both
the need for RCTs and the role of pragmatic study
methodology, however, this study may have identified a
potentially novel target for interventions to improve par-
ticipation in surgical trials: the surgeons themselves.
Integrating education within trials may be one way in
which this goal may be achieved [9], but changing the
culture of surgical research, creating research capacity
and educating the next generation of surgeons about the
need for and value of RCTs as a fundamental part of
their training may be the most effective long-term strat-
egy for improving recruitment into future surgical trials
[5,54]. The Royal College of Surgeons of England re-
cently published a number of recommendations regard-
ing the future of surgical research [77] and initiated
plans to create a surgical trials infrastructure through
the creation of an Institute of Surgical Research and re-
gional trials units [78]. Integral to these changes is the
incorporation of research modules into surgical training
[77]. In time, implementation of these recommendations
may address some of the issues relating to the lack of fa-
miliarity with trial methodology identified in this study
and help to ensure that surgical trials are better ac-
cepted. An apprenticeship model of ‘see one, do one,
teach one’ may be a starting place to change the culture
of trial participation by surgeons.
Indeed, there is already evidence that the culture of
surgical research in the United Kingdom is changingwith the rise of the surgical trainee research collaboratives.
The trainee collaborative concept, which originated in the
West Midlands has been rapidly disseminated throughout
the United Kingdom, and subspecialty collaboratives in
orthopaedic and plastic surgery and neurosurgery have
also been established [79,80]. The innovative model of
trainees at different hospitals working together has been
shown to be an effective and efficient means of delivering
large, multicentre audit projects [81] and high-quality sur-
gical trials [82]. Trainees are highly motivated to partici-
pate in such studies and gain familiarity with research
methodology as well as developing valuable practical re-
search skills such as recruiting patients into trials. As such,
trainee networks have the potential to build research cap-
acity and make a significant contribution to clinical re-
search [80].
For surgical trainees to be fully engaged with this
model, however, changes are required in the way in which
research participation and achievements are assessed,
both during and at the end of training. The current
need to generate academic output for career progres-
sion has hindered participation in high-quality clinical
research because trainees’ efforts have been diverted
into writing up case reports and case series with little
awareness of their methodological limitations or toward
pursuing more traditional laboratory-based projects in
which the required outputs are more easily achieved.
Moves are underway to address this issue, and evidence
of recruitment of patients into surgical trials and partici-
pation in collaborative clinical research, rather than the
number of publications, are likely to become minimum
future requirements for completion of surgical specialist
training.
Conclusions
There is currently a need for well-designed, pragmatic,
multicentre RCTs in many areas of surgery, including
BR. At present, however, many professionals do not ap-
pear to appreciate the need for RCTs. Furthermore,
undertaking a pragmatic RCT is likely to be hampered
by surgeons’ limited familiarity with and understanding
of this methodology. Interventions to educate surgeons
and to allow them to gain familiarity with and confi-
dence in the process may be an essential prerequisite to
undertaking such work. Education of the next generation
of surgeons by changing the culture of surgical research
may be key to unlocking the potential of RCTs in
surgery.
Additional file
Additional file 1: Study Topic Guides. Health-care professional
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investigate the feasibility of clinical trials in breast reconstruction.
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